Anne Marie Z Jukic1, Anne Z Steiner, Donna D Baird. 1. From the 1Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC; and 2Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC.
Abstract
OBJECTIVE: Vitamin D has been linked to antimüllerian hormone levels, suggesting a possible association with greater ovarian reserve, but large population-based studies are lacking. Our objective was to explore the association between vitamin D and follicle-stimulating hormone (FSH) in premenopausal women. METHODS: The Uterine Fibroid Study (1996-1999) enrolled randomly selected 30- to 49-year-old members of a Washington, DC, health plan (N = 1,430). Women provided blood and urine samples in addition to questionnaire data. The vitamin D metabolite 25-hydroxyvitamin D (25(OH)D) was measured in stored plasma samples. Urinary FSH (mIU/mg creatinine) was measured by immunofluorometric assay. To obtain baseline measures, we limited this investigation to urine samples collected in the first 5 days of the menstrual cycle or 5 days before menses onset. In addition, postmenopausal women and women using oral contraceptives were excluded, leaving 527 women for analysis. FSH was creatinine-adjusted, normalized by log transformation, and modeled with multivariable linear regression. RESULTS: The median 25(OH)D level was 12 ng/mL, with approximately 75% of participants below the recommended level of 20 ng/mL. FSH and 25(OH)D were inversely related. For every 10-ng/mL increase in 25(OH)D, urinary FSH decreased by 14% (95% CI, -23 to -5; P = 0.003). CONCLUSIONS: Vitamin D is inversely related to FSH. This is consistent with literature relating low vitamin D levels to lower antimüllerian hormone levels. Prospective studies should investigate whether low vitamin D levels contribute to decreased ovarian reserve.
OBJECTIVE:Vitamin D has been linked to antimüllerian hormone levels, suggesting a possible association with greater ovarian reserve, but large population-based studies are lacking. Our objective was to explore the association between vitamin D and follicle-stimulating hormone (FSH) in premenopausal women. METHODS: The Uterine Fibroid Study (1996-1999) enrolled randomly selected 30- to 49-year-old members of a Washington, DC, health plan (N = 1,430). Women provided blood and urine samples in addition to questionnaire data. The vitamin D metabolite 25-hydroxyvitamin D (25(OH)D) was measured in stored plasma samples. Urinary FSH (mIU/mg creatinine) was measured by immunofluorometric assay. To obtain baseline measures, we limited this investigation to urine samples collected in the first 5 days of the menstrual cycle or 5 days before menses onset. In addition, postmenopausal women and women using oral contraceptives were excluded, leaving 527 women for analysis. FSH was creatinine-adjusted, normalized by log transformation, and modeled with multivariable linear regression. RESULTS: The median 25(OH)D level was 12 ng/mL, with approximately 75% of participants below the recommended level of 20 ng/mL. FSH and 25(OH)D were inversely related. For every 10-ng/mL increase in 25(OH)D, urinary FSH decreased by 14% (95% CI, -23 to -5; P = 0.003). CONCLUSIONS:Vitamin D is inversely related to FSH. This is consistent with literature relating low vitamin D levels to lower antimüllerian hormone levels. Prospective studies should investigate whether low vitamin D levels contribute to decreased ovarian reserve.
Authors: Nicola A Dennis; Lisa A Houghton; Gregory T Jones; Andre M van Rij; Kirstie Morgan; Ian S McLennan Journal: J Clin Endocrinol Metab Date: 2012-04-16 Impact factor: 5.958
Authors: Anne Z Steiner; Amy H Herring; James S Kesner; Juliana W Meadows; Frank Z Stanczyk; Steven Hoberman; Donna D Baird Journal: Obstet Gynecol Date: 2011-04 Impact factor: 7.661
Authors: Zaher O Merhi; David B Seifer; Jeremy Weedon; Oluwatoyin Adeyemi; Susan Holman; Kathryn Anastos; Elizabeth T Golub; Mary Young; Roksana Karim; Ruth Greenblatt; Howard Minkoff Journal: Fertil Steril Date: 2012-04-10 Impact factor: 7.329
Authors: Ellen B Gold; Sybil L Crawford; Nancy E Avis; Carolyn J Crandall; Karen A Matthews; L Elaine Waetjen; Jennifer S Lee; Rebecca Thurston; Marike Vuga; Siobán D Harlow Journal: Am J Epidemiol Date: 2013-06-20 Impact factor: 4.897
Authors: Ayse Gul Kebapcilar; Mustafa Kulaksizoglu; Levent Kebapcilar; Mustafa Sait Gonen; Ali Unlü; Ali Topcu; Fatih Demirci; Cüneyt Eftal Taner Journal: Menopause Date: 2013-01 Impact factor: 2.953
Authors: Alexandra C Purdue-Smithe; Brian W Whitcomb; Kathleen L Szegda; Maegan E Boutot; JoAnn E Manson; Susan E Hankinson; Bernard A Rosner; Lisa M Troy; Karin B Michels; Elizabeth R Bertone-Johnson Journal: Am J Clin Nutr Date: 2017-05-10 Impact factor: 7.045
Authors: Huichu Li; Jaime E Hart; Shruthi Mahalingaiah; Rachel C Nethery; Trang VoPham; Elizabeth Bertone-Johnson; Francine Laden Journal: Environ Res Date: 2021-08-21 Impact factor: 6.498
Authors: Michał Ciebiera; Marta Włodarczyk; Magdalena Ciebiera; Kornelia Zaręba; Krzysztof Łukaszuk; Grzegorz Jakiel Journal: Int J Mol Sci Date: 2018-07-14 Impact factor: 5.923